BI
IBBQ icon

Beckerman Institutional’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Beckerman Institutional’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$374K Buy
11,456
+426
+4% +$12.6K 0.18% 103
2026
Q1 		$320K Buy
11,030
+265
+2% +$7.71K 0.17% 101
2025
Q4 		$306K Buy
10,765
+166
+2% +$4.52K 0.17% 104
2025
Q3 		$258K Buy
+10,599
New +$244K 0.15% 104

Other funds holding IBBQ

Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
WG
WMS Group Folsom, Louisiana $77.5M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
KAM
Knightsbridge Asset Management Newport Beach, California $762M AUM 59.13% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return
CFA
Churchill Financial Advisors Louisville, Kentucky $519M AUM
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Beckerman Institutional's IBBQ Position: Q2 2026 in Review

Beckerman Institutional increased its Invesco NASDAQ Biotechnology ETF (IBBQ) stake by 3.9% in Q2 2026, buying an estimated $12.6K and bringing the position to 11,456 shares worth $374K. The position accounts for 0.18% of the portfolio, ranked #103.

Beckerman Institutional first reported a position in IBBQ in Q3 2025 and has held it in 4 quarters since. 35 funds tracked by Wall St. Rank hold IBBQ as of Q2 2026.

  • Beckerman Institutional held 11,456 shares of Invesco NASDAQ Biotechnology ETF worth $374K as of Q2 2026.
  • Beckerman Institutional bought 426 Invesco NASDAQ Biotechnology ETF shares in Q2 2026, an estimated $12.6K.
  • Invesco NASDAQ Biotechnology ETF made up 0.18% of Beckerman Institutional's portfolio in Q2 2026, its #103 holding.
  • Beckerman Institutional first reported a position in Invesco NASDAQ Biotechnology ETF in Q3 2025 and has held it in 4 quarters since.
  • 35 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q2 2026.

Based on Beckerman Institutional's 13F filing for Q2 2026, filed 11 Aug 2026.